"Viral Proteins/administration and dosage"[MeSH] - Search Results

Year	Number of Results
1970	1
1971	5
1972	15
1973	23
1974	21
1975	45
1976	22
1977	23
1978	33
1979	14
1980	8
1981	7
1982	12
1983	13
1984	14
1985	22
1986	16
1987	21
1988	29
1989	32
1990	25
1991	25
1992	35
1993	35
1994	36
1995	30
1996	23
1997	45
1998	45
1999	55
2000	69
2001	78
2002	76
2003	77
2004	96
2005	135
2006	143
2007	89
2008	110
2009	88
2010	116
2011	144
2012	136
2013	112
2014	119
2015	117
2016	121
2017	125
2018	121
2019	92
2020	83
2021	78
2022	13
2024	0

1

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo.

Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen ZY, Liu DR. Zuris JA, et al. Nat Biotechnol. 2015 Jan;33(1):73-80. doi: 10.1038/nbt.3081. Epub 2014 Oct 30. Nat Biotechnol. 2015. PMID: 25357182 Free PMC article.

2

Targeting Head and Neck Cancer by Vaccination.

Wang C, Dickie J, Sutavani RV, Pointer C, Thomas GJ, Savelyeva N. Wang C, et al. Front Immunol. 2018 Apr 23;9:830. doi: 10.3389/fimmu.2018.00830. eCollection 2018. Front Immunol. 2018. PMID: 29740440 Free PMC article. Review.

3

Intracellular delivery: exploiting viral membranotropic peptides.

Galdiero S, Vitiello M, Falanga A, Cantisani M, Incoronato N, Galdiero M. Galdiero S, et al. Curr Drug Metab. 2012 Jan;13(1):93-104. doi: 10.2174/138920012798356961. Curr Drug Metab. 2012. PMID: 22292812 Review.

4

Recent advances in mucosal immunization using virus-like particles.

Vacher G, Kaeser MD, Moser C, Gurny R, Borchard G. Vacher G, et al. Mol Pharm. 2013 May 6;10(5):1596-609. doi: 10.1021/mp300597g. Epub 2013 Apr 24. Mol Pharm. 2013. PMID: 23548071 Review.

5

Central nervous system distribution of the poxviral proteins after intranasal administration of proteins and titering of vaccinia virus in the brain after intracranial administration.

Kulkarni AP, Govender D, Kellaway LA, Kotwal GJ. Kulkarni AP, et al. Methods Mol Biol. 2012;890:305-26. doi: 10.1007/978-1-61779-876-4_18. Methods Mol Biol. 2012. PMID: 22688775

6

Plant-derived antigens as mucosal vaccines.

Mason HS, Herbst-Kralovetz MM. Mason HS, et al. Curr Top Microbiol Immunol. 2012;354:101-20. doi: 10.1007/82_2011_158. Curr Top Microbiol Immunol. 2012. PMID: 21811930 Free PMC article. Review.

7

Surface modulatable nanocapsids for targeting and tracking toward nanotheranostic delivery.

Stark M, Cheng RH. Stark M, et al. Pharm Pat Anal. 2016 Sep;5(5):307-17. doi: 10.4155/ppa-2016-0021. Pharm Pat Anal. 2016. PMID: 27610752 Free PMC article. Review.

8

Second-generation prophylactic HPV vaccines: successes and challenges.

Tyler M, Tumban E, Chackerian B. Tyler M, et al. Expert Rev Vaccines. 2014 Feb;13(2):247-55. doi: 10.1586/14760584.2014.865523. Epub 2013 Dec 18. Expert Rev Vaccines. 2014. PMID: 24350614 Free PMC article. Review.

9

Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study.

Rungrojcharoenkit K, Sunintaboon P, Ellison D, Macareo L, Midoeng P, Chaisuwirat P, Fernandez S, Ubol S. Rungrojcharoenkit K, et al. PLoS One. 2020 Aug 6;15(8):e0237218. doi: 10.1371/journal.pone.0237218. eCollection 2020. PLoS One. 2020. PMID: 32760143 Free PMC article.

10

Influenza vaccination for HIV-positive people: Systematic review and network meta-analysis.

Zhang W, Sun H, Atiquzzaman M, Sou J, Anis AH, Cooper C. Zhang W, et al. Vaccine. 2018 Jun 27;36(28):4077-4086. doi: 10.1016/j.vaccine.2018.05.077. Epub 2018 May 30. Vaccine. 2018. PMID: 29859802 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,823 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,823 results

Results by year